Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia Bosch F; Muntanola A; Gine E; Carrio A; Villamor N; Moreno C; Crespo M; Montserrat ECytometry B Clin Cytom 2006[Jul]; 70 (4): 214-7Chronic lymphocytic leukemia (CLL) is a disease with an extremely heterogeneous prognosis. Because of this and because of the lack of a truly effective therapy, treatment of CLL must be adapted to the individual risk of each patient. Over the last quarter of century, prognosis of patients with CLL has been based on clinical features. In the last few years a number of biological prognostic parameters have been identified. Among them, the expression of ZAP-70 in neoplastic B lymphocytes is increasingly being recognized as of paramount importance to predict outcome. Patients with a low percentage (<20%) of ZAP-70 positive neoplastic B lymphocytes have a much better prognosis that those with a higher proportion (>20%) of ZAP-70 positive neoplastic B lymphocytes.|Biomarkers, Tumor/analysis/biosynthesis/genetics[MESH]|Flow Cytometry/methods[MESH]|Gene Expression Regulation, Leukemic[MESH]|Humans[MESH]|Immunoglobulin Heavy Chains/genetics[MESH]|Immunoglobulin Variable Region/genetics[MESH]|Leukemia, Lymphocytic, Chronic, B-Cell/*diagnosis/immunology/therapy[MESH]|Mutation[MESH]|Prognosis[MESH]|ZAP-70 Protein-Tyrosine Kinase/analysis/*biosynthesis/genetics[MESH] |